These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
476 related items for PubMed ID: 18533276
1. A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro. Wang X, Xu W, Tong D, Ni J, Gao H, Wang Y, Chu Y, Li P, Yang X, Xiong S. Immunol Lett; 2008 Aug 15; 119(1-2):71-7. PubMed ID: 18533276 [Abstract] [Full Text] [Related]
3. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Woo PC, Lau SK, Tsoi HW, Chen ZW, Wong BH, Zhang L, Chan JK, Wong LP, He W, Ma C, Chan KH, Ho DD, Yuen KY. Vaccine; 2005 Oct 10; 23(42):4959-68. PubMed ID: 15993989 [Abstract] [Full Text] [Related]
4. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses. Huang J, Cao Y, Du J, Bu X, Ma R, Wu C. Vaccine; 2007 Sep 28; 25(39-40):6981-91. PubMed ID: 17709158 [Abstract] [Full Text] [Related]
5. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV. Liu YV, Massare MJ, Barnard DL, Kort T, Nathan M, Wang L, Smith G. Vaccine; 2011 Sep 02; 29(38):6606-13. PubMed ID: 21762752 [Abstract] [Full Text] [Related]
13. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. ter Meulen J, van den Brink EN, Poon LL, Marissen WE, Leung CS, Cox F, Cheung CY, Bakker AQ, Bogaards JA, van Deventer E, Preiser W, Doerr HW, Chow VT, de Kruif J, Peiris JS, Goudsmit J. PLoS Med; 2006 Jul 02; 3(7):e237. PubMed ID: 16796401 [Abstract] [Full Text] [Related]
14. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S. Virology; 2005 Mar 30; 334(1):74-82. PubMed ID: 15749124 [Abstract] [Full Text] [Related]
17. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Du L, Zhao G, Chan CC, Sun S, Chen M, Liu Z, Guo H, He Y, Zhou Y, Zheng BJ, Jiang S. Virology; 2009 Oct 10; 393(1):144-50. PubMed ID: 19683779 [Abstract] [Full Text] [Related]
18. Identification of a B-cell antigenic epitope at the N-terminus of SARS-CoV M protein and characterization of monoclonal antibody against the protein. Qian C, Qin D, Tang Q, Zeng Y, Tang G, Lu C. Virus Genes; 2006 Oct 10; 33(2):147-56. PubMed ID: 16972028 [Abstract] [Full Text] [Related]